October 18-20 | Tucson, AZ

The Research Institution GAP Fund and Accelerator Program Summit

Oxford biotech startup Nightstar Therapeutics plans US NASDAQ float

Get our GAP Insights Newsletter

Join Upcoming Events

October 18-20, 2023 / Tucson, AZ
The annual summit for research institution gap fund and accelerator programs, including proof of concept programs, startup accelerators, and university venture funds

The Story

Founded in 2014, the company has developed a technology that could cure blindness.

Nightstar is the latest in a number of UK-based healthcare companies looking to US markets for IPOs. Investors in the US are said to have a better understanding of biotech, which leads them to value early-stage companies at higher amounts.

Nightstar is set to float at an estimated valuation of $250m.

The firm has raised funds through three rounds of investment, the most recent of which raised $45m in June.

The London Stock Exchange has not lost out on all recent floats in the sector, however. Last month, biotech company Destiny Pharma said it was plotting a London float.

Source: Oxford biotech startup Nightstar Therapeutics plans US float | City A.M.

Get the Report

More GAP News